p.kowalski
Submits third-party assay reports on material purchased directly. Based in Kumasi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.19%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041427 | Retatrutide | QYB | QYB-2604-B4920 | PeptideMeter | 2026-Q3 | 97.93 | 2.45 | 101.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041808 | Exenatide | ASY | ASY-{CAT}-2827 | Janoshik | 2026-Q2 | 99.32 | 4.59 | 95.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042762 | Semax | GGPeps | GGPE-2602-Y9952 | Janoshik | 2026-Q2 | 99.90 | 5.48 | 104.4 | Supplier-supplied | 0 | PASS |
| AX-2026-043110 | Epitalon | KP | KP-2508-Y5884 | PeptideMeter | 2026-Q1 | 98.77 | 7.55 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042626 | Tirzepatide | SWB | SWB-2601-V7010 | PeptideMeter | 2026-Q1 | 98.71 | 4.62 | — | Laboratory-retained | 0 | PASS |
| AX-2025-018991 | Tirzepatide | ASY | ASY-{CAT}-1938 | Medutest | 2025-Q3 | 99.09 | 4.30 | 102.2 | Buyer-sourced | 0 | PASS |
| AX-2025-018930 | Tirzepatide | TFS | TFS-{CAT}-9918 | PeptideMeter | 2025-Q2 | 97.06 | 4.61 | 88.8 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-019605 | GHRP-2 | TFC | TFC-2411-A2083 | Janoshik | 2025-Q1 | 99.76 | 1.87 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004459 | Mazdutide | SinoPep | SNP-2408-A4044 | Janoshik | 2024-Q3 | 99.29 | 4.01 | 104.1 | Supplier-supplied | 0 | PASS |
| AX-2024-004221 | Liraglutide | WWB | WWB-2406-R3462 | Janoshik | 2024-Q3 | 99.58 | 2.23 | 96.0 | Buyer-sourced | 0 | PASS |